---
figid: PMC3398867__pone.0041017.g009
figlink: /pmc/articles/PMC3398867/figure/pone-0041017-g009/
number: F9
caption: Cell proliferation and survival of human lung cancer cells harboring activated
  mutant EGFR (PC9 and 11–18 cells) closely depend upon EGFR-driven PI3K/Akt pathway,
  and this proliferation/survival is highly susceptible to erlotinib and other EGFR
  TKIs. First, there is partial or complete loss of mEGFR gene allele in drug-resistant
  cell lines, and then gain of addiction to HER2/HER3 and PI3K/Akt signaling (PC9/ER1
  cells). However, more definitive analysis on resistant cell lines of 11–18 is required
  because 11–18 resistant cell lines show only partial loss of mEGFR.
pmcid: PMC3398867
papertitle: Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance
  to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells.
reftext: Keisuke Tabara, et al. PLoS One. 2012;7(7):e41017.
pmc_ranked_result_index: '5455'
pathway_score: 0.8691567
filename: pone.0041017.g009.jpg
figtitle: Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to
  EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells
year: '2012'
organisms:
- Homo sapiens
ndex: 4a357d91-de9e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3398867__pone.0041017.g009.html
  '@type': Dataset
  description: Cell proliferation and survival of human lung cancer cells harboring
    activated mutant EGFR (PC9 and 11–18 cells) closely depend upon EGFR-driven PI3K/Akt
    pathway, and this proliferation/survival is highly susceptible to erlotinib and
    other EGFR TKIs. First, there is partial or complete loss of mEGFR gene allele
    in drug-resistant cell lines, and then gain of addiction to HER2/HER3 and PI3K/Akt
    signaling (PC9/ER1 cells). However, more definitive analysis on resistant cell
    lines of 11–18 is required because 11–18 resistant cell lines show only partial
    loss of mEGFR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - PIK3R5
  - ERBB3
  - PIK3R6
  - PIK3R3
  - PIK3CG
  - AKT3
  - PIK3R4
  - EGFR
  - PIK3CB
  - AKT2
  - AKT1
  - PIK3CD
  - PIK3CA
genes:
- word: (EGFR,HER2,HER3)
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: (EGFR,HER2,HER3)
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: WEGFR/EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
chemicals: []
diseases: []
figid_alias: PMC3398867__F9
redirect_from: /figures/PMC3398867__F9
figtype: Figure
---
